Entourage Health to Hold First Quarter 2024 Financial Results Call on May 28
May 14, 2024 07:30 ET
|
Entourage Health Corp.
TORONTO, May 14, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX: ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis...
Kroma Announces Spectrum’s Launch Alongside Expansion Plans
May 14, 2024 07:30 ET
|
Kroma
Seoul, Korea, May 14, 2024 (GLOBE NEWSWIRE) -- Kroma has unveiled the highly anticipated launch of Spectrum, an advanced, native, staking service that aims to revolutionize the Ethereum Layer-2...
ETFS Capital Calls on WisdomTree to Stop Fighting Stockholders and Run a Strategic Process
May 14, 2024 07:30 ET
|
ETFS Capital Limited
WisdomTree Board Attempting to Distract from its Inability to Explain or Defend Persistent Undervaluation of the Core ETF Business 2024 Annual Meeting a Referendum on the Board and Management’s...
FitLife Brands Announces First Quarter 2024 Results
May 14, 2024 07:30 ET
|
FitLife Brands, Inc.
Omaha, May 14, 2024 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. (“FitLife” or the “Company”) (NASDAQ: FTLF), a provider of innovative and proprietary nutritional supplements and wellness products,...
Pliant Therapeutics Announces Positive Topline Data from a Phase 2a Collagen PET Imaging Clinical Trial of Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis
May 14, 2024 07:30 ET
|
Pliant Therapeutics, Inc.
12-week treatment with Bexotegrast 160 mg resulted in reduction of total lung collagen as measured by PET imaging, compared to an increase on placebo Improvement in FVC and reduction in...
Gain Therapeutics Reports Financial Results for First Quarter 2024 and Provides Corporate Update
May 14, 2024 07:30 ET
|
Gain Therapeutics, Inc.
BETHESDA, Md., May 14, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the...
Vivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference Call
May 14, 2024 07:30 ET
|
Vivos Therapeutics, Inc
LITTLETON, Colo., May 14, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and technology company specializing in the development...
Anavex Life Sciences to Present at the H.C. Wainwright 2nd BioConnect Investor Conference at NASDAQ
May 14, 2024 07:30 ET
|
Anavex Life Sciences Corp.
NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics...
NowVertical Welcomes David Doritty as Independent Director
May 14, 2024 07:30 ET
|
NowVertical Group Inc
TORONTO, May 14, 2024 (GLOBE NEWSWIRE) -- NowVertical Group Inc. (“NowVertical” or the “Company”) (TSX-V: NOW) (OTCQB: NOWVF), is pleased to announce the appointment of David Doritty, who currently...
HealthEquity Closes Acquisition of BenefitWallet HSA Portfolio
May 14, 2024 07:30 ET
|
HealthEquity, Inc.
DRAPER, Utah, May 14, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (Nasdaq: HQY) ("HealthEquity"), the leader in Health Savings Account (HSA) and consumer-directed benefits administration, is pleased...
- May 14, 2024 07:30 ET Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024
- May 14, 2024 07:30 ET Pliant Therapeutics Announces Positive Topline Data from a Phase 2a Collagen PET Imaging Clinical Trial of Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis